A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma

NCT01185548 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated based on safety results from another trial

Conditions

Lymphoma
Advanced Cancer

Interventions

DRUG: Tolbutamide
DRUG: Tasisulam

Sponsor

Eli Lilly and Company